GLP-1 drugs and PCOS: what the evidence actually supports

What did @everythingpcos actually say?

Here's the honest answer upfront: the transcript provided for this video is not health content. The audio captured is song lyrics, not the creator's spoken claims about PCOS or GLP-1 medications. What we have to work from is the caption, which does make several specific claims worth examining on their own terms.

In the caption, the creator says GLP-1 medications are helping people with PCOS manage "insulin resistance," reduce "inflammation," get "regular cycles," and improve chances of "ovulation." These are real, specific physiological claims. They're also the kinds of claims that spread fast in the PCOS community and deserve more than a thumbs-up emoji in response. So let's actually look at them.

Does the science back this up?

Partially, yes, but the picture is more complicated than the caption suggests. The strongest evidence is on insulin resistance. GLP-1 receptor agonists like semaglutide and liraglutide do improve insulin sensitivity, and insulin resistance is a core metabolic driver in roughly 70% of people with PCOS (Stepto et al., 2013, Journal of Clinical Endocrinology and Metabolism). That part holds up.

On cycles and ovulation, there is emerging but limited evidence. A 2023 study by Elkind-Hirsch et al. in Fertility and Sterility found that liraglutide improved menstrual regularity and ovulation rates in women with PCOS and obesity, but the sample sizes were small and the results aren't ready to be called definitive. The inflammation claim is biologically plausible. Semaglutide has shown anti-inflammatory effects in cardiovascular studies (Ridker et al., 2021, New England Journal of Medicine), but PCOS-specific inflammation data is thin. Calling it established would be a stretch.

What did they get wrong (or right)?

The creator gets credit for connecting GLP-1s to insulin resistance in PCOS. That connection is real and underappreciated in mainstream conversation. Too many people still think GLP-1 drugs are purely weight loss tools. They're not, and in PCOS specifically, the metabolic mechanism matters more than the number on the scale for some patients.

Where the caption oversimplifies: framing regular cycles and ovulation as outcomes you can expect from GLP-1s alone is premature. Cycle regularity in PCOS is multi-factorial. Weight loss itself, regardless of how it's achieved, can restore ovulation in some patients. It's not always the GLP-1 mechanism doing the work. Attributing that outcome specifically to the drug class, without that caveat, gives people an incomplete picture. If you're using this information to make decisions about trying to conceive, that gap matters.

The "getting my body back" framing is also worth flagging. It's emotionally resonant and not dishonest, but it can set expectations that GLP-1s will fix everything. For a meaningful portion of PCOS patients, they won't.

What should you actually know?

GLP-1 receptor agonists are not FDA-approved specifically for PCOS. That doesn't mean they don't work for PCOS-related symptoms. It means prescribing them for this purpose is off-label, and the evidence base, while growing, is still catching up to the social media enthusiasm.

If you have PCOS and insulin resistance, GLP-1s may be a legitimate conversation to have with a provider. The American Association of Clinical Endocrinology now includes GLP-1 agonists in its obesity and metabolic management guidelines in ways that overlap with PCOS management. But "a real chance at ovulation" is a phrase that requires a real clinical evaluation, not a TikTok caption. Anyone trying to conceive with PCOS should be working with a reproductive endocrinologist, not building a treatment plan from social media.

• GLP-1s are not a fertility treatment. They may support conditions that make fertility harder, but that is different from treating infertility.
• Not every person with PCOS has insulin resistance. Phenotype matters. A drug that helps one presentation may do little for another.
• Weight loss from any intervention can restore cycles. Attributing this solely to the GLP-1 mechanism is not always accurate.